Meeting Individualized Migraine Treatment Needs: Clinical Experience Roundtables

Overview

This interactive session will bring together healthcare professionals in a peer-to-peer learning environment focused on migraine diagnosis and treatment. The program will address current unmet needs in migraine care and discuss branded treatment options, highlighting the role of CGRP pathway inhibition in reducing the symptoms and frequency of migraine attacks. Attendees will also engage with expert faculty, Merle Diamond, MD; Jessica Horwitz, FNP-BC; Deborah Friedman, MD; and Yazen Joudeh, MD, in small groups to discuss real-life patient cases and explore individualized treatment approaches that demonstrate how a CGRP receptor antagonist may be used to meet patients' personalized needs for acute or preventive migraine treatment. Due to limited availability, registration will be confirmed on a first-come, first-served basis.